Stay updated on Nivolumab and Axitinib in RCC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Axitinib in RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Axitinib in RCC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision: v3.3.4 replaces v3.3.3 in the study documents section, with no changes to core study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:43:38.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    Locations section consolidated under a single Locations heading, listing Maryland, New York, and Pennsylvania. Previous separate subsections for Maryland Locations, New York Locations, and Pennsylvania Locations were removed.
    Difference
    0.4%
    Check dated 2025-12-23T20:56:41.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T11:32:26.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The government funding lapse notice about NIH operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:15:24.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    The Study Record Dates section now includes additional update timestamps (e.g., 2025-10-29, 2026-04-06, 2026-10-06, 2025-10-28) and updates the label to Last Update Posted (Estimated).
    Difference
    0.8%
    Check dated 2025-11-03T21:21:00.000Z thumbnail image
  8. Check
    108 days ago
    Change Detected
    Summary
    Update includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.
    Difference
    3%
    Check dated 2025-10-06T06:00:12.000Z thumbnail image

Stay in the know with updates to Nivolumab and Axitinib in RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Axitinib in RCC Clinical Trial page.